These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2349578)

  • 1. Purification and physiological study of a hypotensive factor from the venom of Vipera aspis aspis (aspic viper).
    Komori Y; Sugihara H
    Toxicon; 1990; 28(4):359-69. PubMed ID: 2349578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and biochemical properties of a kallikrein-like enzyme from the venom of Vipera aspis aspis (aspic viper).
    Komori Y; Sugihara H
    Toxicon; 1988; 26(12):1193-203. PubMed ID: 3238703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new inhibitor for angiotensin converting enzyme from the venom of Vipera aspis aspis.
    Komori Y; Sugihara H
    Int J Biochem; 1990; 22(7):767-71. PubMed ID: 2169439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological study of muscle degenerating hemorrhagic factor from the venom of Vipera aspis aspis (aspic viper).
    Komori Y; Sugihara H
    Int J Biochem; 1988; 20(12):1417-23. PubMed ID: 3072227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of factor X activator from the venom of Vipera aspis aspis.
    Komori Y; Nikai T; Sugihara H
    Int J Biochem; 1990; 22(9):1053-60. PubMed ID: 2282962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of procoagulant from the venom of Vipera aspis aspis.
    Komori Y; Nikai T; Sugihara H
    Int J Biochem; 1993 May; 25(5):761-7. PubMed ID: 8349017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the lethal components in Vipera aspis aspis and Vipera aspis zinnikeri venom.
    Komori Y; Nikai T; Sugihara H
    J Nat Toxins; 1998 Jun; 7(2):101-8. PubMed ID: 9678184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper).
    Komori Y; Nikai T; Taniguchi K; Masuda K; Sugihara H
    Biochemistry; 1999 Sep; 38(36):11796-803. PubMed ID: 10512636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and pharmacological properties of phospholipases A2 from Vipera russelli (Russell's viper) snake venom.
    Huang HC; Lee CY
    Toxicon; 1984; 22(2):207-17. PubMed ID: 6729839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and properties of a proteinase from Vipera lebetina (snake) venom.
    Mähar A; Siigur E; Siigur J
    Biochim Biophys Acta; 1987 Sep; 925(3):272-81. PubMed ID: 3304428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of three phospholipases A2 from the venom of Vipera aspis aspis.
    Komori Y; Nikai T; Sugihara H
    Jpn J Med Sci Biol; 1990 Dec; 43(6):253-4. PubMed ID: 2101147
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification and partial biochemical characterization of an edema inducing phospholipase A2 from Vipera russelli (Russell's viper) snake venom.
    Vishwanath BS; Kini RM; Gowda TV
    Toxicon; 1988; 26(8):713-20. PubMed ID: 3188061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a major phospholipase A2 from Russell's viper (Vipera russelli) venom.
    Kasturi S; Gowda TV
    Toxicon; 1989; 27(2):229-37. PubMed ID: 2718191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of the main coagulant and anticoagulant principles of Vipera russellii snake venom.
    Teng CM; Chen YH; Ouyang C
    Biochim Biophys Acta; 1984 May; 786(3):204-12. PubMed ID: 6722170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of three phospholipase A2s from the venom of Vipera aspis.
    Komori Y; Nikai T; Sugihara H
    Comp Biochem Physiol B; 1990; 97(3):507-14. PubMed ID: 2286065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical assessment of immunoreactivity of a new purified equine F(ab')2 against European viper venom.
    Pepin-Covatta S; Lutsch C; Lang J; Scherrmann JM
    J Pharm Sci; 1998 Feb; 87(2):221-5. PubMed ID: 9519157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of an anticoagulant proteinase, cerastase F-4, from Cerastes cerastes (Egyptian sand viper) venom.
    Daoud E; Tu AT; el-Asmar MF
    Thromb Res; 1986 Apr; 42(1):55-62. PubMed ID: 3010494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequences and structural organization of phospholipase A2 genes from Vipera aspis aspis, V. aspis zinnikeri and Vipera berus berus venom. Identification of the origin of a new viper population based on ammodytin I1 heterogeneity.
    Guillemin I; Bouchier C; Garrigues T; Wisner A; Choumet V
    Eur J Biochem; 2003 Jul; 270(13):2697-706. PubMed ID: 12823540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratogenic and lethal properties of the various fractions of venom of the viper, Vipera aspis.
    Gabriel-Robez O; Clavert J
    Acta Anat (Basel); 1980; 108(2):226-9. PubMed ID: 7405539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A platelet function inhibitor purified from Vipera russelli siamensis (Smith) snake venom.
    Li YS; Liu KF; Wang QC; Ran YL; Tu GC
    Toxicon; 1985; 23(6):895-903. PubMed ID: 4095704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.